Wize Pharma down 9% on underwhelming LO2A data in eye disorder - Seeking Alpha

Wize Pharma down 9% on underwhelming LO2A data in eye disorder  Seeking Alpha

Thinly traded nano cap Wize Pharma ([[WIZP]] -8.5%) is down on more than a 4x surge in volume, albeit on turnover of only 128K shares, in reaction to its a.